In conclusion, lncRNA BCAR4 promotes ESCC tumorigenesis via regulating p53/p21 signaling pathway and develops a brand-new biomarker and medicine target for ESCC. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.